Morgan Stanley: These 2 Stocks Could Surge 230%

Morgan Stanley just revealed two stocks that could surge substantially in the next 12 months. Here are their NAME and TICKER symbols. Morgan Stanley (NYSE: MS) just revealed… Two biotech stocks that could surge substantially in the next 12 months. But I doubt they have the same 1,355% potential that [these 5 stocks have.]( [Go here now for urgent details.]( In a new note to clients… Morgan Stanley analyst Mike Wilson made the case for biotech in a falling rate environment. In his own words: “With rate cuts on the horizon, we recently discussed the case for Biotech to show relative outperformance as the Fed begins reducing the policy rate. Our analysis around prior cycles supports the notion that Biotech tends to outperform the market in periods of falling interest rates… We think this is driven by the sensitivity of biotech valuation to discount rates and the expectation for greater M&A activity on the back of falling yields, particularly around Fed cutting cycles.” Here are the two biotech picks Morgan Stanley recommends: - CervoMed (NASDAQ: CRVO) - Viking Therapeutics (NASDAQ: VKTX) But in my view, [this Oppenheimer Project]( is a much better profit opportunity. That’s why Warren Buffett… Bill Gates… and Jeff Bezos are investing billions in it. Want to see why it could make you a 1,355% gain? [Simply go here now for urgent details]( Ian Wyatt ** By clicking the above link you will be registered for our next event "The Oppenheimer Project" - keep an eye on your inbox for details ** [Take a 7 day break from these emails]( © Wyatt Investment Research. All rights reserved. Wyatt Investment Research is not a broker dealer of financial advisor. This content is for informational purposes. Nothing in this email should be considered investment advice. Every investment has risk and you could lose your investment. You can review terms of use and disclosures by [clicking here.]( You are subscribed with the following email address: {EMAIL} [Unsubscribe from these types of emails]( [Manage your email preferences]( We love hearing from subscribers. Please reply to this email with any feedback or suggestions. Contact abuse@wyattresearchnewsletters.com to report any issues or concerns. For questions regarding your account please call [866-447-8625](tel:+1(866)447-8625). Wyatt Investment Research LLC 65 Railroad Street, PO Box 790 Richmond, Vermont USA 05477 ---------------------------------------------------------------